Lipigon Pharmaceuticals AB (publ) (STO:LPGO)
Sweden
· Delayed Price · Currency is SEK 0.305
+0.013 (4.28%)
Mar 25, 2025, 1:32 PM CET
STO:LPGO Market Cap
STO:LPGO has a market cap or net worth of 43.31 million as of March 25, 2025. Its market cap has decreased by -14.99% in one year.
Market Cap
43.31M
Enterprise Value
32.58M
Revenue
8.97M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.30
Market Cap Chart
Since March 1, 2021, STO:LPGO's market cap has decreased from 97.91M to 43.31M, a decrease of -55.76%. That is a compound annual growth rate of -18.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2025 | 43.31M | 153.03% |
| Dec 30, 2024 | 17.12M | -68.59% |
| Dec 29, 2023 | 54.49M | 240.70% |
| Dec 30, 2022 | 15.99M | -74.72% |
| Dec 30, 2021 | 63.26M | -35.39% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 99.74B |
| Getinge AB | 60.14B |
| Sectra AB | 48.99B |
| Camurus AB | 36.27B |
| Medicover AB | 30.40B |
| Vitrolife AB | 23.06B |
| Bonesupport Holding AB | 21.85B |
| Elekta AB | 21.47B |